TABLE 2.
Univariate analysis of relationship between eGFR and variables in hypertensive patients
| Variable | r | P‐value |
|---|---|---|
| Age, years | −0.02 | .85 |
| BMI, kg/m2 | −0.15 | .08 |
| SBP, mmHg | −0.04 | .64 |
| DBP, mmHg | 0.02 | .85 |
| Plasma glucose, mg/dL | −0.23 | .01 |
| Hemoglobin, g/dL | 0.34 | <.001 |
| HbA1c, % | −0.30 | .001 |
| LDL cholesterol, mg/dL | −0.01 | .89 |
| HDL cholesterol, mg/dL | 0.12 | .16 |
| LDL/HDL | −0.06 | .48 |
| Triglyceride, mg/dL | −0.06 | .49 |
| BNP, pg/mL | −0.34 | <.001 |
| Urinary vanin‐1, ng/mg Cr | −0.39 | <.001 |
| Urinary NGAL, ng/ mg Cr | −0.21 | .01 |
| Urinary KIM‐1, ng/mg Cr | −0.05 | .55 |
Abbreviations: BMI, body mass index; BNP, B‐type natriuretic peptide; Cr, creatinine; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; KIM‐1, kidney injury molecule‐1; LDL, low‐density lipoprotein; NGAL, neutrophil gelatinase‐associated lipocalin;SBP, systolic blood pressure.